Upgrade to SI Premium - Free Trial

Adverum Biotechnologies (ADVM) PT Lowered to $4.50 at Chardan Capital Markets

November 2, 2018 9:05 AM
Chardan Capital Markets analyst Gbola ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst PT Change

Next Articles